Third-Party Tested by Verum Analytics
Dual GIP/GLP-1 receptor agonist — next-generation weight loss and metabolic-health peptide.
Third-Party Tested by Verum Analytics
Albert's Verdict
GLP2-T's intestinal trophic effects are highly localized — the receptor distribution in the gut mucosa is what makes it interesting as a standalone metabolic research target, separate from the GLP-1 pathway entirely.
View COA✓ In stock - Ships same day
Arrives as lyophilized (powder) form
Shipped freeze-dried for maximum stability and shelf life. See laboratory preparation guide for handling instructions.
GLP2-T is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist — a next-generation metabolic peptide that consistently outperforms single-pathway GLP-1 agonists in weight-loss and diabetes trials.
Clinical data has demonstrated 15–22% body-weight reduction, superior blood-glucose control, appetite suppression, and preserved lean mass. The 2024 SUMMIT trial showed a 38% reduction in cardiovascular death or worsening heart failure (HR 0.62). One of the most powerful research peptides available for metabolic-pathway studies. For research use only. Not for human or veterinary consumption.
Commonly studied alongside in laboratory settings
Frequently asked questions about this compound for laboratory researchers.
Peer-reviewed literature relevant to GLP2-T research. Linked PubMed IDs open the original source.
6 verified buyers
I use to take ZEPBOUND. But then my insurance quit covering it. So I ordered the GLP2. I’ve been taking it for 2 months now. It helps curb my appetite a little bit, but not as much as I had hoped. I’m gonna try it one more month and if that doesn’t work, then I have to figure out something different to help with my weight loss.
Product performed in research that lined up with the disclosed purity and quality tests. Shipping was timely, and product arrived undamaged and properly protected. Bioinfinty Labs lives up to the hype!
Packaged great, quick shipping, easy customer service
Easy reconstitution, excellent quality and purity. Well packaged and good price.
Shipped quick, reconstituted easy great quality.
The product was easy to reconstitute and came with appropriate packaging that I found very useful for the integrity of the product. It was shipped quickly and no issues with packaging.
Reviews are submitted by verified buyers via per-order tokenized links. Reviews are evaluated for product-focused content; any review containing therapeutic claims (cured, treats, healed, etc.) may be edited or hidden to maintain compliance with FDA and platform guidelines.
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.
GLP2-T (Tirzepatide) is an FDA-approved dual GIP/GLP-1 receptor agonist. 2026 meta-analyses confirm superiority over semaglutide: -22.1% weight loss vs -17.1% at 12 months, with 95.2% achieving ≥10% loss. SURPASS trials show HbA1c reductions of 1.8-2.4%. Ongoing cardiovascular outcomes study (NCT07096063) compares long-term MACE endpoints vs semaglutide.
Research status
clinical investigational
Molecular weight
4813.45 g/mol
Molecular formula
C225H348N48O68
For research use only. This summary is a research-scientific overview compiled from peer-reviewed sources. It is not medical advice and is not intended for human or veterinary consumption.